Project information
Vývoj postupů pro léčbu makulární degenerace sítnice deriváty lidských pluripotentních kmenových buněk
- Project Identification
- NU22-08-00629
- Project Period
- 5/2022 - 12/2025
- Investor / Pogramme / Project type
-
Ministry of Health of the CR
- Ministry of Health Research Programme 2020 - 2026
- Subprogram 1 - standard
- MU Faculty or unit
- Faculty of Medicine
- Cooperating Organization
-
St. Anne's University Hospital Brno
- Responsible person doc. RNDr. Irena Koutná, Ph.D.
Vývoj postupů pro léčbu makulární degenerace sítnice deriváty lidských pluripotentních kmenových buněk
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.
Publications
Total number of publications: 7
2024
-
DEVELOPMENT TOWARDS THERAPY OF MACULAR DEGENERATION OF RETINA BY DERIVATIVES OF HUMAN PLURIPOTENT STEM CELLS
Year: 2024, type: Conference abstract
-
Quality Control of Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cells for Regenerative Therapy
Year: 2024, type: Conference abstract
-
Truncated vitronectin with e-cadherin enables the xeno-free derivation ofhuman embryonic stem cells
Year: 2024, type: Appeared in Conference without Proceedings
2023
-
Quality control of clinical-grade human embryonic stem cells
Year: 2023, type: Appeared in Conference without Proceedings
-
Truncated vitronectin with E-cadherin enables the xeno-free derivation of human embryonic stem cells
Scientific Reports, year: 2023, volume: 13, edition: 1, DOI
-
Vitronectin is a xeno-free and defined surface for the derivation of human embryonic stem cells
Year: 2023, type: Conference abstract
2022
-
The Manufacture of Xeno- and Feeder-Free Clinical-Grade Human Embryonic Stem Cell Lines: First Step for Cell Therapy
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 20, DOI